UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High grade serous ovarian carcinomas originate in the fallopian tube

Nature communications, 2017-10, Vol.8 (1), p.1093-11, Article 1093

2017

Volltextzugriff (PDF)

Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors

The Journal of pathology, 2018-12, Vol.246 (4), p.459-469

2018

Volltextzugriff (PDF)

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (16), p.5423-5434

2011

Volltextzugriff (PDF)

Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer

Gynecologic oncology, 2014-03, Vol.132 (3), p.542-550

2014

Volltextzugriff (PDF)

Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study)

BMJ open, 2023-02, Vol.13 (2), p.e065902-e065902

2023

Volltextzugriff (PDF)

Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics

International journal of cancer, 2023-11, Vol.153 (9), p.1568-1578

2023

Volltextzugriff (PDF)

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer

Clinical cancer research, 2018-01, Vol.24 (2), p.326-333

2018

Volltextzugriff (PDF)

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response

Critical reviews in oncology/hematology, 2016-05, Vol.101, p.50-59

2016

Volltextzugriff (PDF)

Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer

Seminars in cancer biology, 2021-12, Vol.77, p.127-143

2021

Volltextzugriff (PDF)

Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study

Swiss medical weekly, 2023-03, Vol.153 (3), p.40055

2023

Volltextzugriff (PDF)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Scientific reports, 2020-11, Vol.10 (1), p.19248-19248, Article 19248

2020

Volltextzugriff (PDF)

584 Overcoming resistance to PARP inhibitor in ovarian cancer with BRCA2 reversion mutation

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A346-A346

2024

Volltextzugriff (PDF)

Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (20), p.5188-5197

2012

Volltextzugriff (PDF)

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours

Nature communications, 2024-05, Vol.15 (1), p.4430-4430, Article 4430

2024

Volltextzugriff (PDF)

Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor

Oncogene, 2023-11, Vol.42 (48), p.3543-3544

2023

Volltextzugriff (PDF)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Scientific reports, 2020-04, Vol.10 (1), p.7073-7073, Article 7073

2020

Volltextzugriff (PDF)

Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity

BMJ open, 2023-01, Vol.13 (1), p.e067691

2023

Volltextzugriff (PDF)

Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study

Swiss medical weekly, 2023-12, Vol.153 (12), p.3504

2023

Volltextzugriff (PDF)

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

Oncoimmunology, 2012-07, Vol.1 (4), p.432-440

2012

Volltextzugriff (PDF)

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer

Journal of translational medicine, 2017-10, Vol.15 (1), p.199-199, Article 199

2017

Volltextzugriff (PDF)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

Oncoimmunology, 2012-05, Vol.1 (3), p.380-382

2012

Volltextzugriff (PDF)

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review

Annals of translational medicine, 2020-12, Vol.8 (24), p.1712-1712

2020

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(69)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(37)
Humans
(32)
Oncology
(27)
Female
(24)
Ovarian Cancer
(17)
Cancer
(15)
Tumors
(14)
Adult
(13)
Breast Cancer
(13)
Middle Aged
(13)
Aged
(9)
Life Sciences
(9)
Brca1 Protein - Genetics
(8)
Brca2 Protein - Genetics
(8)
Retrospective Studies
(8)
Chemotherapy
(7)
Germ-Line Mutation
(7)
Ovarian Neoplasms - Genetics
(7)
Antineoplastic Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High grade serous ovarian carcinomas originate in the fallopian tube

Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer

Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study)

Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response

Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer

Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

584 Overcoming resistance to PARP inhibitor in ovarian cancer with BRCA2 reversion mutation

Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours

Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity

Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer

Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms

Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review

Suchergebnisse filtern